INTRODUCTION
============

The incidence of intracranial aneurysm (IA) in general population has been reported to be approximately 2% and the annual risk of IA rupture causing subarachnoid hemorrhage (SAH) was 1.9%.^[@R1],[@R2]^ Aneurysmal subarachnoid hemorrhage (aSAH) constitutes about 85% of overall SAH, which accounts for 5% of all cases of stroke.^[@R3]^ Despite the development of intensive care and neurosurgical therapy, mortality of aSAH remains 27% to 50%^[@R3]--[@R5]^ and only around 60% of survival can be cured without disability.^[@R6]^ The high morbidity and mortality of aSAH make it a major public health problem. Yet, the main cause of IA remains obscure. Previous epidemiological studies have revealed innate (heritable connective tissue disorders, familial predisposition, and female gender) and postnatal (smoking and hypertension) factors of IA formation.^[@R7],[@R8]^ At the same time, pathophysiology researches also showed that hemodynamic factors, inflammatory factors, and elevated arterial blood pressure played important roles in the pathogenesis of IAs.^[@R8]--[@R10]^ In the past decades, with the improvement of genetics and molecular biology, gene factors of IA were intensively investigated and polymorphisms of eNOS were one of the focuses.

Nitric oxide (NO), also known as "endothelial-derived relaxing factor,"^[@R11]^ is mostly produced by the catalyzing action of the 3 nitric oxide synthase (NOS) family enzymes via the conversion of L-arginine.^[@R12]^ It is a multifunctional molecule and participates in a large number of biological reactions, for example, active biological mediator in relaxing vascular smooth muscle in response to vasoactive substances and shear stress,^[@R11]^ vasodilatation maintenance the structure of the vessel wall,^[@R13]^ inhibiting vascular smooth muscle cell proliferation,^[@R14]^ and platelet and monocyte adhesion.^[@R15],[@R16]^ A substantial part of NO functions may participate in the mechanism of aneurysms formation and downregulation of NO level has been reported to be associated with several vascular diseases.^[@R17]^

The 3 members of NOS family are neuronal (nNOS/NOS1), inducible (iNOS/NOS2), and endothelial (eNOS/NOS3).^[@R18]^ eNOS that is found primarily in the endothelium continuously generating NO serves to maintain basal vascular tone and cerebral blood flow, and its dysregulation may participate in the early development of aneurysms.^[@R19]^ eNOS is encoded by gene located on chromosome 7*q*35--36 that has 26 exons that span \>21 kb of the genome (GenBank D26607).^[@R20]^ There are many functional polymorphisms in different regions of eNOS gene and several studies have been done to elucidate the relationships between polymorphisms and susceptibility of IAs. The T786C (rs2070744) is an important point mutation of thymine to cytosine at coden-786 in the 5′-flanking region of the eNOS gene, which could significantly reduce eNOS gene promoter activity and serum NO level^[@R21]^; G894T (Glu298Asp, rs1799983) corresponds to a Glu-Asp change at nucleotide 298 in exon 7 that demonstrated a trend for a reduced eNOS enzyme activity,^[@R22]^ and 27-bp-VNTR that is a variable number of tandem repeats (VNTRs, 27 bp) in intron 4 accounts influencing basal plasma NO generation.^[@R23]^ T786C, G894T, and 27-bp-VNTR were the 3 most clinically relevant IA-associated polymorphisms in the eNOS gene that have been reported. From 2003, these 3 polymorphisms have been reported to be associated with IA risk in a number of case--control studies with conflicting conclusions.^[@R24]--[@R36]^ In this study, we performed meta-analyses and corresponding stratified analyses using currently available data to clarify the effects of eNOS T786C, G894T, and 27-bp-VNTR polymorphisms on the risk of IAs.

MATERIALS AND METHODS
=====================

Publication Search
------------------

We searched the articles using the following terms: "intracranial aneurysm," "cerebral aneurysm," "brain aneurysm," "SAH," "subarachnoid hemorrhage" in combination with "polymorphism," "variant" in combination with "eNOS," and "endothelial nitric oxide synthase" in PubMed, Web of Science, Ovid & Embase, and Chinese Wanfang databases from the established date to July 15, 2014. The reference lists of relevant articles were also retrieved to find additional articles. There was no limitation on language or publication year.

Selection Criteria
------------------

Studies selected for further meta-analysis must meet the following criteria: case--control studies, reports about associations between eNOS T786C, G894T, or 27-bp-VNTR polymorphism and risk of IA, and inclusion of genotype frequencies of case and control subjects to perform the related statistical analysis. Duplicated reports, reviews, meta-analysis articles, and meeting abstracts without adequate information were excluded. If multiple studies involved same subjects, only the complete one was used in the analysis. Results of article selection were compared and discrepancies were resolved by consensus.

Data Extraction
---------------

The following data was extracted carefully and independently by 2 authors from each eligible study: first author\'s last name, publication year, country, size of the study population (case/control), race, source of the control subjects, genotyping method, endpoint of IAs, percentage of female gender, mean age, and related genotype numbers of cases and controls. Any disagreements were resolved by discussion between the 2 authors.

Statistical Analysis
--------------------

The Hardy--Weinberg equilibrium (HWE) for control subjects of each study was evaluated by Pearson goodness-of-fit χ^2^ test. To evaluate the relationship between eNOS polymorphisms (T786C, G894T, 27-bp-VNTR) and risk of IAs, crude odds ratios (ORs) and their 95% confidence intervals (CIs) were applied. Three genetic models, for example, codominant, dominant, and recessive models, were used to determine the pooled OR. For T786C polymorphism, the codominant model was represented by heterozygous comparison of TC vs TT and homozygous comparison of CC vs TT, the dominant model was CC + TC vs TT and the recessive model was CC vs TC + TT. For G894T, the codominant model was heterozygous comparison of TG vs GG and homozygous comparison of TT vs GG, the dominant model was TT + TG vs GG and the recessive model was TT vs TG + GG. For 27-bp-VNTR polymorphism, the codominant model was represented by heterozygous comparison of ab vs bb and homozygous comparison of aa vs bb, the dominant model was aa + ab vs bb and the recessive model was aa vs ab + bb. Since the frequency of mutation homozygous genotype was equal to zero, studies by Song et al^[@R29]^ for T786C polymorphism and Kim et al^[@R32]^ for G894T polymorphism were excluded in recessive model and homozygous comparison of codominant model.^[@R37]^

Heterogeneity between studies was evaluated by Q test and I^2^ statistic. Heterogeneity was considered significant when *P* \< 0.05 in Q test.^[@R38]^ Low heterogeneity is considered when I^2^ \< 25%, moderate heterogeneity when I^2^ = 25% to 50%, and high heterogeneity I^2^ \> 50%.^[@R39]^

The fixed-effects model was subsequently used to calculate the pooled ORs when *P* \> 0.05. Otherwise, the random-effects model was applied. Subgroup analyses were performed by endpoint of IAs (RIA and mixed), racial descent (Asian and Caucasian), and control source (hospital-based \[HCC\] and population-based case--control \[PCC\] study). Sensitivity analysis was conducted by sequential removing each individual study and possible publication bias was calculated by the Begg^[@R40]^ and the Egger tests.^[@R41]^ The STATA software version 12.0 (STATA Corporation, College Station, TX) was used to carry out all statistical analysis.

RESULTS
=======

Study Selection and Subject Characteristics
-------------------------------------------

The flow diagram of study selection procedure was shown in Figure [1](#F1){ref-type="fig"}. A total of 88 articles were originally identified, including 22 from PubMed, 26 from Web of Science, 36 from Ovid & Embase, and 4 from Chinese Wanfang database. No additional finding through screening article reference was retrieved. After evaluating articles according to selection criteria, 13 articles including 11 published journal articles and 2 unpublished academic dissertations were eligible for this meta-analysis. Two studies by Khurana et al^[@R24],[@R25]^ shared some common subjects. The study^[@R24]^ only concerning T786C polymorphism contains more cases than the other about T786C, G894T, and 27-bp-VNTR polymorphisms. Therefore, the former study was included in the meta-analysis of T786C polymorphism and the later was employed in G894T and 27-bp-VNTR polymorphisms. One article by Akagawa et al^[@R26]^ reported 2 studies in Japan and Korea and both of the studies met the selection criteria; therefore, we included them as single study.

![Flowchart showing the different phases of the meta-analysis.](medi-94-e452-g001){#F1}

Characteristics of the Studies
------------------------------

Table [1](#T1){ref-type="table"} summarizes the characteristics of included studies. The ruptured IA (RIA) in all studies was verified during surgery and the unruptured IA (UIA) was diagnosed by angiography or surgical findings. Completed genotype information was obtained and HWE tests in the controls were calculated (Table [2](#T2){ref-type="table"}). Genotype distribution in most control groups was consistent with HWE with some exceptions.^[@R25],[@R28],[@R31],[@R35]^ There were 10 studies in 9 articles including 1819 cases and 1893 controls for the eNOS T786C polymorphism. Five studies were carried out in Asians and 5 in Caucasians. Four studies used population-based control subjects and 6 used hospital-based control subjects (Tables [1](#T1){ref-type="table"} and [2](#T2){ref-type="table"}). Furthermore, 5 studies used RIA patients as case subjects and the other 5 used both RIA and UIA patients.

###### 

Study Characteristics of Individual Studies Included in the Meta-Analysis
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###### 

Genotype Information for Main Meta-Analysis

![](medi-94-e452-g003)

For eNOS G894T polymorphism IAs analysis, 9 studies involving 1393 cases and 1508 controls were identified for our meta-analysis. In the 9 studies, 4 were Asians and 5 Caucasians. Three of these studies were of PCC design, whereas the other 6 studies were of HCC design. Cases in the 5 studies came from RIA patients and 4 were from RIA and UIA patients (Tables [1](#T1){ref-type="table"} and [2](#T2){ref-type="table"}).

eNOS 27-bp-VNTR polymorphism was conducted for 1281 cases and 1406 controls in 7 studies. Subjects of 3 studies originated from Asian populations, whereas the other 4 were from Caucasian populations. Controls were recruited randomly from hospitals in 4 studies or the general population in 3 studies. RIA patients were used as cases in 4 studies, and RIA and UIA patients were used in 3 studies (Tables [1](#T1){ref-type="table"} and [2](#T2){ref-type="table"}).

Meta-Analysis
-------------

Table [3](#T3){ref-type="table"} shows the main results of this meta-analysis and the heterogeneity test of the eNOS T786C, G894T, and 27-bp-VNTR polymorphisms and IAs. For the 3 polymorphisms, the combined results based on all studies did not show any significant associations between the polymorphisms and IAs risk for all genetic models (Table [3](#T3){ref-type="table"}). As stratified by ethnicity, our results showed that T786C polymorphism was associated with increased risk of IA in dominant model (CC + TC vs TT; OR = 1.277, 95% CI = 1.019--1.600) and heterozygous comparison of codominant model (TC vs TT; OR = 1.294, 95% CI = 1.025--1.634) among Asians (Figures [2](#F2){ref-type="fig"} and [3](#F3){ref-type="fig"}), but the association did not emerge in the other genetic models of Asians or among Caucasians (Table [3](#T3){ref-type="table"}). Furthermore, there was no evidence for the association between the other 2 polymorphisms and IA risk in stratified analysis based on the source of controls, ethnicity, or endpoint of IA (Table [3](#T3){ref-type="table"}).

###### 

Pooled ORs and 95% CIs of Meta-Analysis
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![Forest plot of ORs with a fixed-effect model for association between the eNOS T786C polymorphism and subgroup IA risk under codominant model (TC vs TT). eNOS = endothelial nitric oxide synthase, OR = odds ratio.](medi-94-e452-g005){#F2}

![Forest plot of ORs with a fixed-effect model for association between the eNOS T786C polymorphism and subgroup IA risk under dominant model (TC + CC vs TT). eNOS = endothelial nitric oxide synthase, OR = odds ratio.](medi-94-e452-g006){#F3}

Test of Heterogeneity and Sensitivity Analyses
----------------------------------------------

The heterogeneity test showed that there was no significant between-study heterogeneity in terms of the eNOS T786C polymorphism (Table [3](#T3){ref-type="table"}). However, significant heterogeneity in G894T polymorphism (homozygous comparison of codominant model: P~h~ = 0.023, I^2^ = 56.7%; dominant model: P~h~ = 0.026, I^2^ = 54.2%; and recessive model: P~h~ = 0.036, I^2^ = 53.4%), and 27-bp-VNTR polymorphism (homozygous comparison of codominant: P~h~ = 0.001, I^2^ = 73.5%; dominant model: P~h~ = 0.001, I^2^ = 71.1%) (Table [3](#T3){ref-type="table"}) was observed. To explore the potential sources of heterogeneity across studies, we assessed the pooled ORs under all comparisons via subgroup and sensitivity analyses. In the subgroup analysis by race, the heterogeneity of G894T was significant in the Asian studies. When stratified by source of control and endpoint of cases, heterogeneity of G894T in population-based studies and RIA cases group was significant in all models except heterozygous comparison of codominant models (Table [3](#T3){ref-type="table"}). It is interesting that when we excluded the Asian population-based controls study with RIA cases by Xu,^[@R35]^ the heterogeneity was significantly decreased in all genetic models. So we can say that the study by Xu^[@R35]^ contributed to substantial heterogeneity of G894T polymorphism. In the stratified study of 27-bp-VNTR polymorphism, heterogeneity was significant in Caucasian and population-based studies when subgrouped by racial and source of control. Similarly, when we excluded a study with Caucasian subjects and population-based controls by Khurana et al,^[@R25]^ the heterogeneity of homozygous comparison of codominant and dominant models for 27-bp-VNTR polymorphism was obviously reduced. So the study by Khurana et al^[@R25]^ may contribute to heterogeneity of 27-bp-VNTR polymorphism. Furthermore, sensitivity analysis was performed to evaluate the stability of the results by excluding 1 single study at a time. The overall association between T786C polymorphism and IA risk was significantly influenced by the study of Staalsø et al.^[@R34]^ When excluding the study by Staalsø et al, an increased risk of significance was associated with T786C polymorphism in heterozygous comparison of codominant model (OR = 1.266, 95% CI = 1.050--1.526) and dominant model (OR = 1.255, 95% CI = 1.049--1.503) (Figures [4](#F4){ref-type="fig"} and [5](#F5){ref-type="fig"}). The pooled ORs and corresponding 95% CIs were not significantly altered when any individual study was excluded for the other models of T786C and all models of G894T and 27-bp-VNTR polymorphisms (data not shown).

![Sensitivity analyses of eNOS T786C polymorphism in TC vs TT model. eNOS = endothelial nitric oxide synthase.](medi-94-e452-g007){#F4}

![Sensitivity analyses of eNOS T786C polymorphism in TC + CC vs TT model. eNOS = endothelial nitric oxide synthase.](medi-94-e452-g008){#F5}

Publication Bias
----------------

The Begg and the Egger tests were applied to evaluate the publication bias. The results of the Begg and the Egger tests suggest possible evidence of publication bias in the meta-analysis of T786C codominant model TC vs TT (Begg *P* = 0.074, Egger *P* = 0.005) and dominant model (Begg *P* = 0.032, Egger *P* = 0.001), also in 27-bp-VNTR codominant model ba vs bb (Begg *P* = 0.230, Egger *P* = 0.024) and dominant model (Begg *P* = 0.230, Egger *P* = 0.015). But no evidence of publication bias in all genetic models of G894T polymorphism was observed (Table [4](#T4){ref-type="table"}). The Begg funnel plot was also constructed and the shape of the plot is consistent with the calculation results (Figures [6](#F6){ref-type="fig"}--[8](#F8){ref-type="fig"}).

###### 

*P* Values for Publication Bias Tests

![](medi-94-e452-g009)

![Begg funnel plot for publication bias test of T786C. (A) TC vs TT. (B) CC vs TT. (C) CC + TC vs TT. (D) CC vs TC + TT, SE = Standard Error.](medi-94-e452-g010){#F6}

![Begg funnel plot for publication bias test of G894T. (A) GT vs GG. (B) TT vs GG. (C) TT + GT vs GG. (D) TT vs GT + GG, SE = Standard Error.](medi-94-e452-g011){#F7}

![Begg funnel plot for publication bias test of 27-bp-VNTR. (A) ab vs bb. (B) aa vs bb. (C) aa + ab vs bb. (D) aa vs ab + bb. VNTR = variable number of tandem repeat, SE = Standard Error.](medi-94-e452-g012){#F8}

DISCUSSION
==========

Because of the versatile NO that has a role in the regulation of vascular tone, hemodynamic changes, and remolding vessel wall, a lot of studies have been done to investigate the contribution made by eNOS polymorphisms to the formation and progression of various vascular diseases.^[@R18]^ Khurana et al^[@R24]^ first investigated the relationship between the T786C polymorphism and IA susceptibility and no significant association was found. After that, 9 studies from 8 articles had been done,^[@R26]--[@R30],[@R32]--[@R34]^ and the result of 5 studies was negative.^[@R27],[@R30],[@R32]--[@R34]^ The other 4 Asian studies have analyzed genotype of cases and controls but did not conclude the association.^[@R26],[@R28],[@R29]^ For G894T, 3 of 9 studies showed significant associations with IA risk,^[@R31],[@R33],[@R35]^ and the other 6 got inverse result.^[@R25],[@R27],[@R28],[@R30],[@R32],[@R34]^ Seven studies investigated 27-bp-VNTR and the risk of IA, and significant association was found in 3 of them,^[@R25],[@R34],[@R36]^ but was not found in the remaining 4.^[@R27],[@R28],[@R30],[@R32]^

A meta-analysis study focusing on the relationship between the 3 eNOS polymorphisms and risk of IA was performed in 2010.^[@R42]^ In that meta-analysis, T786C polymorphism was significantly associated with IA risk, but neither G894T nor 27-bp-VNTR showed significant association. After that, several articles holding different viewpoints about that topic have been published. Here, we conducted a comprehensive meta-analysis to shed light on the role of eNOS polymorphisms in IA risk.

One thousand eight hundred nineteen cases and 1893 controls from 10 studies in 9 articles were eligible for the meta-analysis and no evidence for the association between eNOS T786C polymorphism and IA susceptibility was found in the overall result. However, in subgroup analysis by ethnicity, significant association was found in Asians in heterozygote comparison (OR = 1.294, 95% CI = 1.025--1.634) and the dominant model (OR = 1.277, 95% CI = 1.019--1.600), but not in Caucasians. Given that people in different region share little in environmental backgrounds and lifestyles, this discrepancy in the results between Asians and Caucasians suggested that eNOS T786C polymorphism may play a penetrance role in IA susceptibility in an ethnicity-specific manner. In fact, differences in the distribution of eNOS polymorphisms in Asians and Caucasians have been reported by Tanus-Santos et al.^[@R44]^ In sensitivity analysis, when we deleted 1 Caucasian study by Staalsø et al,^[@R34]^ significant association was observed in heterozygous comparison (OR = 1.266, 95% CI = 1.050--1.526) and dominant model (OR = 1.255, 95% CI = 1.049--1.503). The results of sensitivity analysis indicated that the main meta-analysis may be influenced powerfully by the study of Staalsø et al for its Caucasian subjects and biggest sample size (case = 331, control = 498), as well as the relatively small simple size of the whole study. Therefore, this finding make the result of overall analysis should be explained carefully and confirmed in future studies.

For eNOS G894T and 27-bp-VNTR polymorphisms, there were 9 studies containing 1393 cases vs 1508 controls and 7 studies about 1281 cases vs 1406 controls eligible. We found no significant association between both of the polymorphisms and IA risk, which were consistent with the majority but not all previous studies.^[@R25],[@R27],[@R28],[@R30]--[@R36]^ The studies by Özüm et al,^[@R31]^ Xu,^[@R35]^ and Liu et al^[@R33]^ found association between increased risk of IA and G894T polymorphism. Studies by Khurana et al^[@R25]^ and Kim et al^[@R32]^ found association between increased risk of IA and 27-VNTR polymorphism. The inconsistency of these studies may be explained by differences in population background, source of controls, sample size, and also by chance. In the subgroup according to study design, race, and endpoint of IAs, similar trends with overall results were observed. In sensitivity analysis, our results were not meaningfully influenced by any individual study in all models of G894T and 27-bp-VNTR polymorphisms.

For the 3 polymorphisms of eNOS, 2 studies^[@R28],[@R43]^ tried to investigate their effect to the rupture risk of IAs. The study by Khurana et al^[@R43]^ found evidence of association between all of the 3 polymorphisms and rupture risk of IAs but inverse result was found by Krischek et al.^[@R28]^ In our present meta-analysis, RIA was applied in 7 studies and mixed RIA and UIA in 6 studies (Table [1](#T1){ref-type="table"}), and no study involved the UIA. To explore the potential influence of different endpoint, subgroup analysis by different endpoint was performed, and significant association was found in neither of the group in different models of the 3 eNOS polymorphisms.

Heterogeneity was observed in G894T polymorphism (homozygous comparison of codominant model: P~h~ = 0.023, I^2^ = 56.7%; dominant model: P~h~ = 0.026, I^2^ = 54.2%; and recessive model: P~h~ = 0.036, I^2^ = 53.4%), and 27-bp-VNTR polymorphism (homozygous comparison of codominant: P~h~ = 0.001, I^2^ = 73.5%; dominant model: P~h~ = 0.001, I^2^ = 71.1%). The heterogeneity might arise from different characteristics of selected studies, such as study design, sample sizes, inclusion criteria, ethnicity, endpoint of IAs, and different genotyping methodologies. In the stratification and sensitivity analyses, we found that the study by Xu^[@R35]^ did contribute to potential heterogeneity of G894T polymorphism and the study by Khurana et al^[@R25]^ produced heterogeneity of 27-bp-VNTR polymorphism, whereas influence analysis suggested that the pooled ORs for the G894T and 27-bp-VNTR polymorphisms were not influenced by the 2 studies. In this view, the results of our meta-analysis were reliable.

Evidence of publication bias was observed in codominant model heterozygous comparison and dominant model for both T786C and 27-bp-VNTR polymorphisms in the Begg and the Egger tests. To some extent, the publication bias was inevitable for this study because of the limited databases searched, the little number of eligible studies, and only English and Chinese publications included. Therefore, some unpublished and published studies in other databases or in other languages that may meet the inclusion criteria were likely to be missed.

Some limitations should be admitted when explaining the results of our meta-analysis. First, the number of eligible studies and subjects of studies was not large enough for an integrated analysis, especially for subgroup analyses. Therefore, our results should be explained with caution. Second, some inclusion studies^[@R25],[@R28],[@R31],[@R34]^ whose genotype distribution in control group was not consistent with HWE may do contribute to the bias of the meta-analysis, although the results were not affected by these studies in sensitivity analysis. Finally, our results were based on single-factor estimates without adjustments for other risk factors. Further evaluation of IA risk should pay more attention to the potential interactions among gene--gene, gene--environment, and even different polymorphism loci of the same gene.

In conclusion, our meta-analysis indicates that eNOS T786C polymorphism is associated with elevated IA risk among Asians but not in Caucasians, whereas G894T and 27-bp-VNTR polymorphisms might have no influence on the susceptibility of IA. However, large well-designed studies are needed to be performed using standardized genotyping methods, homogeneous cases, and well-matched controls. In addition, further studies investigating the effect of gene--gene and gene--environment interactions may eventually lead to our better, comprehensive understanding of the association between the eNOS polymorphisms and IA risk.

Abbreviations: aSAH = aneurysmal subarachnoid hemorrhage, eNOS = endothelial nitric oxide synthase, IA = intracranial aneurysm, SAH = subarachnoid hemorrhage.
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